• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Mid-Morning Market Update: Markets Open Lower Amid Ongoing Russia-Ukraine Conflict

    2/28/22 10:38:08 AM ET
    $AUPH
    $CVX
    $EPAM
    $FHN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Integrated oil Companies
    Energy
    Get the next $AUPH alert in real time by email

    U.S. stocks opened on a downbeat note this morning, amid the ongoing Russia-Ukraine conflict, which has led to increased US sanctions on Russia.

    Following the market opening Monday, the Dow traded down 1.38% to 33,587.55 while the NASDAQ fell 0.61% to 13,611.57. The S&P also fell, dropping, 1.12% to 4,335.65.

    Check out this: Insiders Buy Around $98M Of 3 Stocks

    Leading and Lagging Sectors


    Energy shares climbed by 0.8% on Friday. Meanwhile, top gainers in the sector included Renewable Energy Group, Inc. (NASDAQ:REGI), up 38% and Nordic American Tankers Limited (NYSE:NAT) up 21%.


    In trading on Friday, financials shares fell by 2.1%.


    Top Headline


    Dentsply Sirona Inc (NASDAQ:XRAY) reported weaker-than-expected earnings for its fourth quarter.

    Dentsply Sirona’s Q4 FY21 sales increased 0.6% Y/Y to $1.09 billion, missing the consensus of $1.13 billion. Adjusted EPS decreased to $0.76 from $0.87 a year ago and below the consensus of $0.79.

    The company said it expects adjusted EPS of $3.05 - $3.25, up 6% -13% Y/Y, compared to the consensus of $3.19.


    Equities Trading UP


    Renewable Energy Group, Inc. (NASDAQ:REGI) shares shot up 38% to $60.51 after Chevron Corp (NYSE:CVX) announced an agreement to acquire the company.


    Shares of IntriCon Corporation (NASDAQ:IIN) got a boost, shooting 37% to $23.90 after the company agreed to be acquired by an affiliate of Altaris Capital Partners for $241 million. IntriCon also posted Q4 EPS of $0.23.


    First Horizon Corporation (NYSE:FHN) shares were also up, gaining 30% to $23.75 after TD announced acquisition of the company for $25 per share in cash.


    Also check this: Cisco Systems And 3 Other Stocks Sold By Insiders


    Equities Trading DOWN

    Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) shares tumbled 31% to $11.16 after the company reported a wider quarterly loss.


    Shares of Viatris Inc. (NASDAQ:VTRS) were down 23% to $11.13 after the company reported worse-than-expected Q4 sales results and issued FY22 sales guidance below estimates. Biocon Biologics Ltd agreed to acquire Viatris biosimilars assets for up to $3.335 billion in stock and cash.


    EPAM Systems, Inc. (NYSE:EPAM) was down, falling 28% to $276.05 after the company announced it withdrew Q1 and FY22 guidance due to uncertainties related to the events in Ukraine.

    Also check out: Executives Buy Around $1M Of 5 Penny Stocks


    Commodities

    In commodity news, oil traded up 4% to $95.24, while gold traded up 1.7% to $1,919.10.


    Silver traded up 2.3% Monday to $24.56 while copper rose 0.1% to $4.4910.



    Euro zone

    European shares were lower today. The eurozone’s STOXX 600 dropped 1.2%, London’s FTSE 100 fell 1.5%, while Spain’s IBEX 35 Index fell 1.4%. The German DAX declined 2.1%, French CAC 40 dipped 2.8% and Italy’s FTSE MIB Index dipped 2.9%.

    Spain’s current account balance swung to a deficit of EUR 1.31 billion in December versus a year-ago surplus of EUR 0.92 billion. Spain's annual inflation rate increased to 7.4% in February from 6.1% in January.


    Economics


    The US goods trade deficit increased to an all-time high of $ 107.63 billion in January from a revised level of $100.47 billion in the prior month.


    Wholesale inventories increased 0.8% month-over-month to $798.2 billion in January.


    The Chicago PMI dropped to 56.3 points in February from 65.2 points in January.


    The Dallas Fed manufacturing business index climbed to 14.00 for February versus prior reading of 2.00.


    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.


    Data on farm prices for January will be released at 3:00 p.m. ET.

    Check out the full economic calendar here

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 80,567,750 cases with around 973,110 deaths. India confirmed a total of at least 42,924,130 cases and 513,840 deaths, while Brazil reported over 28,768,100 COVID-19 cases with 649,190 deaths. In total, there were at least 436,400,520 cases of COVID-19 worldwide with more than 5,970,270 deaths.

    Get the next $AUPH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AUPH
    $CVX
    $EPAM
    $FHN

    CompanyDatePrice TargetRatingAnalyst
    DENTSPLY SIRONA Inc.
    $XRAY
    2/19/2026$17.00Neutral → Buy
    BofA Securities
    Chevron Corporation
    $CVX
    2/17/2026$205.00Hold → Buy
    Melius
    Viatris Inc.
    $VTRS
    2/9/2026$18.00Neutral → Buy
    UBS
    Chevron Corporation
    $CVX
    2/2/2026$160.00 → $168.00Hold
    TD Cowen
    Chevron Corporation
    $CVX
    2/2/2026$180.00Buy → Hold
    HSBC Securities
    Chevron Corporation
    $CVX
    1/20/2026$176.00Neutral → Overweight
    Analyst
    Viatris Inc.
    $VTRS
    1/16/2026$15.00Hold → Buy
    Argus
    EPAM Systems Inc.
    $EPAM
    1/6/2026$220.00Hold
    Truist
    More analyst ratings

    $AUPH
    $CVX
    $EPAM
    $FHN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    EPAM Named 2026 Top IT Vendor in the Netherlands for 4th Year

    EPAM, a top-three IT service provider in the Netherlands for the fourth consecutive year, achieved exceptional performer status with 88% in application services and 87% in general satisfaction.NEWTOWN, Pa. and AMSTERDAM, March 10, 2026 /PRNewswire/ -- EPAM Systems, Inc. (NYSE:EPAM) today announced it has been named a 2026 Top IT Vendor in the Netherlands by Whitelane Research, an independent organization focused on IT sourcing research across Europe. Recognized for the fourth consecutive year, this designation further confirms EPAM's position as a premier IT service provider in the region.

    3/10/26 2:02:00 AM ET
    $EPAM
    EDP Services
    Technology

    First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics

    Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI1 (ddMRI) system – MAGNETOM Free.Max Dental Edition – has received FDA clearance in the United States. This milestone follows the completion of a clinical trial2 validating the system's significant potential across multiple dental specialties. The trial highlighted this first-of-its-kind technology's applicability in endodontics, periodontics, TMJ, tooth extraction, and orthodontics, offering non-ionizing imaging capabilities that can enhance diagnosis and treatment planning. CHARLOTTE, N.C., March 09, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona and Siemens Healthineers are pleased to sha

    3/9/26 8:30:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    EPAM Enters Into $300 Million Accelerated Share Repurchase Agreement

    NEWTOWN, Pa., March 5, 2026 /PRNewswire/ -- EPAM Systems, Inc. (NYSE:EPAM), a leading digital and AI transformation company, today announced that it has entered into an accelerated share repurchase agreement (ASR) with Morgan Stanley & Co. LLC to repurchase an aggregate of $300 million of its common stock. The ASR was authorized under the Company's existing $1.0 billion share repurchase authorization. "Our accelerated repurchase program demonstrates our confidence in EPAM's long-term outlook and our ability to generate sustained growth through our robust engineering foundation a

    3/5/26 6:05:00 AM ET
    $EPAM
    EDP Services
    Technology

    $AUPH
    $CVX
    $EPAM
    $FHN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Dentsply Sirona upgraded by BofA Securities with a new price target

    BofA Securities upgraded Dentsply Sirona from Neutral to Buy and set a new price target of $17.00

    2/19/26 7:47:02 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Chevron upgraded by Melius with a new price target

    Melius upgraded Chevron from Hold to Buy and set a new price target of $205.00

    2/17/26 7:31:07 AM ET
    $CVX
    Integrated oil Companies
    Energy

    Viatris upgraded by UBS with a new price target

    UBS upgraded Viatris from Neutral to Buy and set a new price target of $18.00

    2/9/26 6:59:24 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AUPH
    $CVX
    $EPAM
    $FHN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lucier Gregory T bought $186,675 worth of shares (15,000 units at $12.45) (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/9/26 4:20:49 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Forbes James D bought $62,400 worth of shares (5,000 units at $12.48), increasing direct ownership by 100% to 10,000 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/9/26 4:19:42 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Lucier Gregory T bought $707,379 worth of shares (50,000 units at $14.15) (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/3/26 7:12:19 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $AUPH
    $CVX
    $EPAM
    $FHN
    SEC Filings

    View All

    SEC Form FWP filed by First Horizon Corporation

    FWP - FIRST HORIZON CORP (0000036966) (Subject)

    3/5/26 5:25:09 PM ET
    $FHN
    Major Banks
    Finance

    Amendment: SEC Form SCHEDULE 13D/A filed by Aurinia Pharmaceuticals Inc

    SCHEDULE 13D/A - Aurinia Pharmaceuticals Inc. (0001600620) (Subject)

    3/3/26 5:30:03 PM ET
    $AUPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Nordic American Tankers Limited

    6-K - NORDIC AMERICAN TANKERS Ltd (0001000177) (Filer)

    3/2/26 4:52:18 PM ET
    $NAT
    Marine Transportation
    Consumer Discretionary

    $AUPH
    $CVX
    $EPAM
    $FHN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LUPKYNIS

    Submission status for AURINIA PHARMACEUTICALS, INC.'s drug LUPKYNIS (ORIG-1) with active ingredient VOCLOSPORIN has changed to 'Approval' on 01/22/2021. Application Category: NDA, Application Number: 213716, Application Classification: Type 1 - New Molecular Entity

    1/25/21 11:31:10 AM ET
    $AUPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AUPH
    $CVX
    $EPAM
    $FHN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Viatris Inc.

    4 - Viatris Inc (0001792044) (Issuer)

    3/10/26 7:03:54 PM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Kilts James M converted options into 24,835 shares, increasing direct ownership by 18% to 161,257 units (SEC Form 4)

    4 - Viatris Inc (0001792044) (Issuer)

    3/10/26 7:03:50 PM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Viatris Inc.

    4 - Viatris Inc (0001792044) (Issuer)

    3/10/26 7:03:50 PM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AUPH
    $CVX
    $EPAM
    $FHN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

    SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    12/6/24 10:11:29 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Aurinia Pharmaceuticals Inc

    SC 13G/A - Aurinia Pharmaceuticals Inc. (0001600620) (Subject)

    11/14/24 4:47:34 PM ET
    $AUPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

    SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    11/14/24 1:22:35 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $AUPH
    $CVX
    $EPAM
    $FHN
    Leadership Updates

    Live Leadership Updates

    View All

    Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors

    CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the "Board"), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experience helping companies develop strategies to drive profitable growth and long-term value creation. Mr. Forbes is widely recognized for advising healthcare companies on complex strategic transactions and capital markets engagements. He most recently served as Vice Chairman of Investment Banking at Morgan Stanley, and he previously held senior execu

    2/24/26 4:30:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    First Horizon Appoints Leilani Farol as Chief Information Security Officer

    MEMPHIS, Tenn., Feb. 11, 2026 /PRNewswire/ -- First Horizon (NYSE:FHN) announced today that Leilani Farol has joined the company as Senior Vice President, Chief Information Security Officer (CISO). In the CISO role, Farol will lead enterprise cybersecurity strategy and execution. She is responsible for continuing to strengthen the company's security posture to safeguard client data and privacy. "Leilani brings more than 25 years of leadership in information security, risk management and technology. We welcome her to the team in this critical role. By continuing to advance our

    2/11/26 10:59:00 AM ET
    $FHN
    Major Banks
    Finance

    Viatris Appoints Matthew J. Maletta as Chief Legal Officer

    Brian Roman to Leave the Company After More Than 20 Years of Exemplary Service; Will Remain Advisor Through Transition Period  PITTSBURGH, Feb. 3, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS) announced today that Matthew J. Maletta has been appointed Chief Legal Officer (CLO), effective February 9, 2026. The appointment follows the transition of the Company's current CLO, Brian Roman, after more than 20 years of exemplary service to Viatris and its predecessor company, Mylan. Roman, who has served in multiple leadership positions and played a key role in supporting the Company's operations, portfolio and growth initiatives, will stay on through April 1, 2026, to ensure a smooth transition

    2/3/26 8:30:00 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AUPH
    $CVX
    $EPAM
    $FHN
    Financials

    Live finance-specific insights

    View All

    Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook

    News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action Plan, prioritizing investments in accelerated innovation, clinical education, and sales team education focused on connected dentistryInitiated new capital allocation strategy by eliminating the dividend

    2/26/26 4:01:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results

    Reports Fourth-Quarter Total Revenues of $3.7B and Full-Year 2025 Total Revenues of $14.3BMeets or Exceeds 2025 Financial Guidance Across All Key Metrics[1]Returns More Than $1B to Shareholders in 2025; Expects Balanced Capital Allocation Approach for 2026Provides 2026 Financial Guidance; Positioned for Sustainable GrowthAnticipates Regulatory Decisions for Six Product Candidates in 2026 and Multiple Important Pipeline MilestonesCompletes Enterprise-Wide Strategic Review; Expects to Deliver $650M in Total Cost Savings With Reinvestment of up to $250M Over the Next 3 YearsPITTSBURGH, Feb. 26, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS) today announced robust financial results for the four

    2/26/26 6:59:00 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend

    PITTSBURGH, Feb. 26, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS) today announced that on February 23, 2026, its Board of Directors approved a 2026 dividend policy of 48 cents ($0.48) per share and declared a quarterly dividend of 12 cents ($0.12) for each issued and outstanding share of the Company's common stock. The dividend is payable on March 18, 2026, to shareholders of record as of the close of business on March 9, 2026. This marks the sixth consecutive year the Company has paid a dividend.                 About Viatris Viatris Inc. (NASDAQ:VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of bo

    2/26/26 6:55:00 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care